Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of CBD and THC on Microbiome and Neuroinflammation in HIV
NCT05514899Phase 2Recruiting
- Sponsor
- University of California, San Diego
- Start
- Sep 2023
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol, cannabidiol in human immunodeficiency virus infection (HIV), sponsored by University of California, San Diego. Started Sep 2023; status: recruiting.
02
Drugs
dronabinolcannabidiol
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT05514899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05514899.